We found that CREM is associated with a variety of cancer-associated pathways, such as focal adhesion, PI3K-Akt signaling pathway, cGMP-PKG signaling, cell adhesion molecules, MAPK signaling pathway, Rap1 signaling pathway, TGF-beta signaling pathway, and Ras signaling pathway. This evidence concerns the gene AKT1 and cancer.